Top 4 Health Care Stocks That Are Preparing To Pump This Month
$GRI
$OSA
$PBLA
$SINT
Biotechnology: Pharmaceutical Preparations
Health Care
Medical Specialities
Health Care
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.
ProSomnus, Inc. (NASDAQ:OSA)
- On Feb. 22, ProSomnus reported successful pilot study validation of next generation remote patient monitoring device for obstructive sleep apnea. The company’s stock fell around 26% over the past five days and has a 52-week low of $0.3450 .
- RSI Value: 29.72
- OSA Price Action: Shares of ProSomnus gained 5.6% to close at $0.5176 on Thursday.
Panbela Therapeutics, Inc. (NASDAQ:PBLA)
- On Feb. 15, Panbela said it regained compliance with Nasdaq listing standards for bid price and publicly held shares requirements. The company’s stock fell around 71% over the past month. It has a 52-week low of $1.06.
- RSI Value: 29.71
- PBLA Price Action: Shares of Panbela Therapeutics fell 3.5% to close at $1.11 on Thursday.
Sintx Technologies, Inc. (NASDAQ:SINT)
- On Feb. 21, SiNtx Technologies entered into second long term supply agreement for aerospace market. The company’s stock fell around 55% over the past month and has a 52-week low of $0.13.
- RSI Value: 29.66
- SINT Price Action: Shares of Sintx Technologies fell 6.4% to close at $0.14 on Thursday.
GRI Bio, Inc. (NASDAQ:GRI)
- On Feb. 2, GRI Bio announced pricing of a $5.5 million public offering. The company’s shares lost around 21% over the past five days. The company’s 52-week low is $0.81.
- RSI Value: 29.28
- GRI Price Action: Shares of GRI Bio dipped 12.9% to close at $0.8450 on Thursday.